 - History of severe defined as grade 3, using the National Cancer Institute Common Toxicity Criteria for Adverse Events, version 4.0 NCI-CTCAE v4 current active minor version allergic or anaphylactic reaction or hypersensitivity to recombinant proteins or excipients 10 mM Tris buffered saline in the investigational agent. 